Evotec SE business relationships
Companies named in Evotec SE’s 20-F filed 2026-04-08, and public companies whose annual reports name Evotec SE. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.5 / 10
- AI naming
- 92 / 100 Top 1% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 35 / 100
Named in Evotec SE’s annual report 8
“Bristol Myers Squibb ("BMS") and Sandoz are the only customers which each individually accounted for more than 10% of group revenues.” SEC filing
“Based on the strength of our molecular CKD patient database, we have built four partnerships in kidney diseases in the last almost ten years with prominent pharmaceutical companies such as Bayer, Vifor (now "CSL Vifor"), Novo Nordisk, Eli Lilly, and Chinook (now a Novartis company).” SEC filing
“Based on the strength of our molecular CKD patient database, we have built four partnerships in kidney diseases in the last almost ten years with prominent pharmaceutical companies such as Bayer, Vifor (now "CSL Vifor"), Novo Nordisk, Eli Lilly, and Chinook (now a Novartis company).” SEC filing
“| | ● | | iPSC-based assay developments : Fate Therapeutics, Allele Biotechnology, Takeda, and Fujifilm, along with Contract Manufacturing Organizations ("CMOs") such as Lonza, SCM Lifescience, Reporcell and Charles River Laboratories. |” SEC filing
“Research Collaboration and License Agreement between Evotec International GmbH and Novo Nordisk A/S, dated July 8, 2020 (incorporated herein by reference to Exhibit 10.13 to the Company's Registration Statement on Form F-1 (File No. 333-260143), as amended, initially filed with the SEC on October 8,...” SEC filing
“BMS antiviral collaboration; Novo Nordisk cell therapy collaboration (total Deal Volume cannot be disclosed, > € 1bn)” SEC filing
“Partnered R&D expenses ended in 2023 with the completion of the previous Sanofi agreement, thus R&D Expense is synonymous with 'Unpartnered R&D Expense' since 2024.” SEC filing
“Based on the strength of our molecular CKD patient database, we have built four partnerships in kidney diseases in the last almost ten years with prominent pharmaceutical companies such as Bayer, Vifor (now "CSL Vifor"), Novo Nordisk, Eli Lilly, and Chinook (now a Novartis company).” SEC filing
Companies whose annual reports name Evotec SE 2
“EVT801 was originally discovered by Sanofi SA and was licensed to Evotec SE as part of a broader transaction.” SEC filing
“License Agreement with Evotec SE” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.